JAZZ News and Press, Jazz Pharmaceuticals plc From 10/18/23

Jazz Pharmaceuticals to Present Latest Advancements in Sleep Medicine at World Sleep 2023 PR Newswire Meeting presentations underscore the increased need for awareness around the cardiovascular and cardiometabolic comorbidities and modifiable risk factors associated with sleep...

Jazz Pharmaceuticals to Showcase Growing Impact in Solid Tumor Oncology Research at ESMO 2023 PR Newswire Zanidatamab data demonstrate clinical potential of novel bispecific antibody in HER2-targeted biliary tract and gastric cancers Additional presentations, including...

2023-10-08 03:55:12 ET Summary Jazz Pharmaceuticals shows robust Q2 revenue and net income growth; supply chain issues and share dilution warrant scrutiny. Strong liquidity suggests the low need for external financing; however, a high debt load balances the financial equation. ...

Originally published in Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report NORTHAMPTON, MA / ACCESSWIRE / October 6, 2023 / A Letter From Our Chairman of the Board and Chief Executive Officer Bruce C. Cozadd I am pleased to share Jazz's 2022 Corporate Sustainabili...

2023-09-29 13:05:39 ET More on AbbVie, Alnylam, etc. AbbVie: Company Vs. Stock, A Gentle Facelift Would Be Nice (Technical Analysis) AbbVie Vs. AstraZeneca: Battle Of The Pharmaceutical Behemoths AbbVie Inc. (ABBV) Morgan Stanley 21st Annual Global Healthcare Brokers...

2023-09-27 14:38:11 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cannabis stocks are undoubtedly a booming opportunity. Many investors consider this sector as a great opportunity to invest and compare it with the artificial intelligence and robotics se...

2023-09-22 10:15:25 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 22, 2023 – USA News Group –  Despite the potential federal funding challenges due to the recent debt ceiling deal , optimism in the b...

2023-09-22 09:29:56 ET More on Jazz Pharma Seeking Alpha’s Quant Rating on Jazz Pharmaceuticals Historical earnings data for Jazz Pharmaceuticals Financial information for Jazz Pharmaceuticals Jazz Pharmaceuticals: Depressed Valuation Opens Up Potentia...

Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze® (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma PR Newswire DUBLIN , Sept. 21, 2023 /PRNewswire/ -- Ja...

2023-09-20 08:30:53 ET NetworkNewsWire Editorial Coverage New York, NY – September 20, 2023 – More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation...